TY - JOUR
T1 - Treatment of Sleep Disorders in Dementia
AU - Ooms, Sharon
AU - Ju, Yo El
N1 - Funding Information:
Yo-El Ju has received a grant from Philips Respironics and personal fees from C2N Diagnostics, the American Academy of Neurology, and the American Academy of Sleep Medicine.
Publisher Copyright:
© 2016, Springer Science+Business Media New York.
PY - 2016/9/1
Y1 - 2016/9/1
N2 - Sleep and circadian disorders occur frequently in all types of dementia. Due to the multifactorial nature of sleep problems in dementia, we propose a structured approach to the evaluation and treatment of these patients. Primary sleep disorders such as obstructive sleep apnea should be treated first. Comorbid conditions and medications that impact sleep should be optimally managed to minimize negative effects on sleep. Patients and caregivers should maintain good sleep hygiene, and social and physical activity should be encouraged during the daytime. Given the generally benign nature of bright light therapy and melatonin, these treatments should be tried first. Pharmacological treatments should be added cautiously, due to the risk of cognitive side effects, sedation, and falls in the demented and older population. Regardless of treatment modality, it is essential to follow patients with dementia and sleep disorders closely, with serial monitoring of individual response to treatment.
AB - Sleep and circadian disorders occur frequently in all types of dementia. Due to the multifactorial nature of sleep problems in dementia, we propose a structured approach to the evaluation and treatment of these patients. Primary sleep disorders such as obstructive sleep apnea should be treated first. Comorbid conditions and medications that impact sleep should be optimally managed to minimize negative effects on sleep. Patients and caregivers should maintain good sleep hygiene, and social and physical activity should be encouraged during the daytime. Given the generally benign nature of bright light therapy and melatonin, these treatments should be tried first. Pharmacological treatments should be added cautiously, due to the risk of cognitive side effects, sedation, and falls in the demented and older population. Regardless of treatment modality, it is essential to follow patients with dementia and sleep disorders closely, with serial monitoring of individual response to treatment.
KW - Alzheimer’s disease
KW - Circadian
KW - Dementia
KW - Dementia with Lewy bodies
KW - Frontotemporal dementia
KW - Insomnia
KW - Lewy body disease
KW - Parkinson’s disease with dementia
KW - REM sleep behavior disorder
KW - Sleep
KW - Vascular dementia
UR - http://www.scopus.com/inward/record.url?scp=84981203336&partnerID=8YFLogxK
U2 - 10.1007/s11940-016-0424-3
DO - 10.1007/s11940-016-0424-3
M3 - Review article
C2 - 27476067
AN - SCOPUS:84981203336
SN - 1092-8480
VL - 18
JO - Current Treatment Options in Neurology
JF - Current Treatment Options in Neurology
IS - 9
M1 - 40
ER -